A smart IUD being developed in Oxfordshire could help fertility research and women’s healthcare by tracking conditions inside the uterus.
Verso Biosense is developing a wireless monitoring device that collects real-time data from inside the uterus, including temperature and oxygen levels.
Researchers hope this will shed light on one of medicine’s least understood organs.
Chief executive Kate Rowley said the technology aims to address a longstanding gap in women’s health research.
Rowley said: “Despite the enormous impact on half the global population, the uterus remains a ‘black box’ in many areas of medicine.
“Continuous monitoring could provide insights we’ve never had before.”
The technology is being explored initially for use in fertility treatment, particularly for women who have experienced unsuccessful IVF cycles.
By monitoring uterine conditions, researchers hope to identify patterns that support successful embryo implantation.
Rowley added that building long-term data sets could ultimately help researchers better understand a range of conditions including endometriosis, PCOS and menopause.
Verso Biosense recently presented at Milton Park’s latest Park Perspectives event, titled ‘Shining a light on women’s health’.
Philip Campbell, commercial director for Milton Park at Federated Hermes Real Estate, said: “Milton Park is home to a vibrant community of life science innovators working at the forefront of research and technology.
“Companies such as Verso Biosense demonstrate how bold thinking and scientific collaboration can lead to breakthroughs that have the potential to improve lives around the world.
“By giving them a platform through our Park Perspective events, it helps bring people together to share ideas and accelerate innovation.”
